Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover.

Developmental cell | 2018

Macroautophagy (autophagy) is intimately linked with cell death and allows cells to evade apoptosis. This has prompted clinical trials to combine autophagy inhibitors with other drugs with the aim of increasing the likelihood of cancer cells dying. However, the molecular basis for such effects is unknown. Here, we describe a transcriptional mechanism that connects autophagy to apoptosis. The autophagy-regulating transcription factor, FOXO3a, is itself turned over by basal autophagy creating a potential feedback loop. Increased FOXO3a upon autophagy inhibition stimulates transcription of the pro-apoptotic BBC3/PUMA gene to cause apoptosis sensitization. This mechanism explains how autophagy inhibition can sensitize tumor cells to chemotherapy drugs and allows an autophagy inhibitor to change the action of an MDM2-targeted drug from growth inhibition to apoptosis, reducing tumor burden in vivo. Thus, a link between two processes mediated via a single transcription factor binding site in the genome can be leveraged to improve anti-cancer therapies.

Pubmed ID: 29533771 RIS Download

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: T32 CA190216
  • Agency: NCI NIH HHS, United States
    Id: R01 CA150925
  • Agency: NCI NIH HHS, United States
    Id: R01 CA117907
  • Agency: NCI NIH HHS, United States
    Id: P30 CA046934
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM007635
  • Agency: NCI NIH HHS, United States
    Id: R01 CA190170

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Purified anti-RNA Polymerase II RPB1 (antibody)

RRID:AB_2616695

This monoclonal targets RNA Polymerase II

View all literature mentions

p62/SQSTM1 Antibody (antibody)

RRID:AB_548364

This monoclonal targets p62/SQSTM1

View all literature mentions

Anti-β-Actin Antibody (antibody)

RRID:AB_476744

This monoclonal targets slightly modified β-cytoplasmic actin N-terminal peptide, Ac-Asp-Asp-Asp-Ile-Ala-Ala-Leu-Val-Ile-Asp-Asn-Gly-Ser-Gly-Lys, conjugated to KLH

View all literature mentions

LC3B Antibody (antibody)

RRID:AB_10003146

This polyclonal targets LC3B

View all literature mentions

PI3 Kinase Class III Antibody (antibody)

RRID:AB_2062856

This unknown targets PI3 Kinase Class III

View all literature mentions

ULK1 (R600) Antibody (antibody)

RRID:AB_2288252

This polyclonal targets ULK1

View all literature mentions

Puma Antibody (antibody)

RRID:AB_2064551

This unknown targets Puma

View all literature mentions

Atg5 (D5G3) Rabbit mAb (antibody)

RRID:AB_10829153

This monoclonal targets Atg5 (D5G3) Rabbit mAb

View all literature mentions

Atg7 (D12B11) Rabbit mAb (antibody)

RRID:AB_10831194

This monoclonal targets Atg7 (D12B11) Rabbit mAb

View all literature mentions